天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook--->CAS DataBase List--->1352226-88-0

1352226-88-0

1352226-88-0 Structure

1352226-88-0 Structure
IdentificationBack Directory
[Name]

AZD6738
[CAS]

1352226-88-0
[Synonyms]

AZD6738
CS-1601
AZD-6738
EOS-61602
Trilacicli
CERALASERTIB
10G,100G,500G
AZD6738(AZD-6738)
CERALASERTIB (AZD6738)
AZD-6738;AZD 6738;AZD6738
AZD6738, Ceralasertib, M6620
(3R)-3-Methyl-4-(6-((2R)-2-((R)-S-methylsulfonimidoyl)cyclopropyl)-2-(1H-pyrrolo[2,3-b]pyridin
(R)-3-methyl-4-(6-(1-((R)-S-methylsulfonimidoyl)cyclopropyl)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl)morpholine
(R)-imino(methyl)(1-(6-((R)-3-methylmorpholino)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl)cyclopropyl)-l6-sulfanone
4-[4-[1-[[S(R)]-S-Methylsulfonimidoyl]cyclopropyl]-6-[(3R)-3-methyl-4-morpholinyl]-2-pyrimidinyl]-1H-pyrrolo[2,3-b]pyridine
1H-Pyrrolo[2,3-b]pyridine, 4-[4-[1-[[S(R)]-S-methylsulfonimidoyl]cyclopropyl]-6-[(3R)-3-methyl-4-morpholinyl]-2-pyrimidinyl]-
(R)-imino(methyl)(1-(6-((R)-3-methylmorpholino)-2-(1H-pyrrolo[2,3-b]pyridin-4-yl)pyrimidin-4-yl)cyclopropyl)-l6-sulfanone (AZD6738)
[EINECS(EC#)]

805-672-6
[Molecular Formula]

C20H24N6O2S
[MDL Number]

MFCD29472273
[MOL File]

1352226-88-0.mol
[Molecular Weight]

412.51
Chemical PropertiesBack Directory
[density ]

1.52±0.1 g/cm3(Predicted)
[storage temp. ]

Hygroscopic, -20°C Freezer, Under inert atmosphere
[solubility ]

DMSO (Slightly), Methanol (Slightly)
[form ]

Solid
[pka]

12.53±0.40(Predicted)
[color ]

Pale Yellow
[InChIKey]

OHUHVTCQTUDPIJ-YEMGFFRQNA-N
[SMILES]

C12NC=CC1=C(C1=NC(N3CCOC[C@H]3C)=CC(C3([S@](C)(=N)=O)CC3)=N1)C=CN=2 |&1:14,19,r|
Safety DataBack Directory
[HS Code ]

2934999090
Hazard InformationBack Directory
[Description]

AZD 6738 is an orally bioavailable inhibitor of the serine/threonine protein kinase ataxia telangiectasia mutated (ATM) and Rad3-related (ATR; IC50 = 1 nM). It can inhibit ATR substrate Chk1 Ser345 phosphorylation in cells with an IC50 value of 74 nM. AZD 6738 has been shown to inhibit the proliferation of various solid and hematological cell lines with IC50 values of less than 1 μM and to reduce tumor growth in several ATM-deficient xenograft models. When used in combination with either DNA damaging chemotherapy agents or ionizing radiation, AZD 6738 demonstrated synergistic cell killing activity across multiple cell lines in vitro and in xenograft studies.
[Uses]

AZD6738 is an orally available morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, ATR kinase inhibitor AZD6738 selectively inhibits ATR activity by blocking the downstream phosphorylation of the serine/threonine protein kinase CHK1. This prevents ATR-mediated signaling, and results in the inhibition of DNA damage checkpoint activation, disruption of DNA damage repair, and the induction of tumor cell apoptosis. In addition, AZD6738 sensitizes tumor cells to chemo- and radiotherapy. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression, and survival; it is activated by DNA damage caused during DNA r
[Application]

Ceralasertib (AZD6738) is a highly selective and potent ATR inhibitor that serves as a key sensor for the detection of DNA damage and a key activator of DNA damage checkpoints. Ceralasertib is currently in clinical development studies for the treatment of metastatic desmoplasia-resistant prostate cancer (mCRPC), advanced/metastatic melanoma, non-small cell lung cancer (NSCLC), prolymphocytic leukemia (PLL), and hairy cell leukemia (HCL), among other solid tumours.
[Mechanism of action]

The anti-tumor effects of an ATR inhibitor, AZD6738, have been investigated in vitro using human gastric cancer cell lines and an in vivo xenograft model. AZD6738 was found to inhibit the proliferation of gastric cancer cells with dysfunctional ATMs by suppressing proliferative signaling and blocking cell-cycle progression in the S phase. Furthermore, AZD6738 disrupted HR-mediated DNA repair in sensitive cells, whereas ATR inhibition activated the ATM-Chk2 pathway to promote the repair of DNA damage induced by AZD6738 in insensitive cells with functional ATM. ATM activation is the main resistance mechanism to AZD6738, and ATM and ATR act compensatively. The study also demonstrates that AZD6738 attenuates ATR activity and induces ATM activation, thus promoting an ATR to ATM switch in the presence of DNA damage. These findings show the interaction between AZD6738 has a synthetic lethal interaction with ATM defect in gastric cancer cells and that ATM inactivation in ATM dysfunctional SNU-601 cells is due to HDAC1 deficiency[4].
[Side effects]

Common side effects of AZD6738 include: anaemia, thrombocytopenia, neutropenia , increased risk of infection, bruising and bleeding, dizziness diarrhoea, loss of appetite, changes in kidney function, tiredness Feeling unwell or sickChanges in kidney function, feeling weak and lack of energy.
[Enzyme inhibitor]

This orally active, and selective ATR kinase inhibitor (FW = 412.51 g/mol; CAS 1352226-88-0; Solubility: 80 mg/mL DMSO; < 1 mg/mL H2O) targets Ataxia Telangiectasia/Rad3-related kinase (IC50 = 1 nM), a serine/threonine protein kinase that activates checkpoint signaling upon genotoxic stresses (e.g., ionizing radiation, ultraviolet light, or replication stalling), thereby serving as a DNA damage sensor. In a model consisting of primary human Chronic Myelogenous Leukemia (CL) cells with biallelic TP53 or ATM inactivation xenotransplanted into NOD/Shi scid/IL-2Rγ mice, AZD6738 provides potent and specific inhibition of ATR signalling with compensatory activation of ATM/p53 pathway in cycling CLL cells in the presence of genotoxic stress. In p53 or ATM defective cells, AZD6738 treatment results in replication fork stalls and accumulation of unrepaired DNA damage, as evidenced by γH2AX and 53BP1 foci formation, carried through into mitosis and resulting in cell death by mitotic catastrophe. AZD6738 displays selective cytotoxicity towards ATM- or p53-deficient CLL cells. AZD6738 also potentiates cisplatin and gemcitabine cytotoxicity in Non-Small-Cell Lung Carcinoma (NSCLC) cell lines with intact ATM kinase signaling. It also potently synergizes with cisplatin in ATM-deficient NSCLC cells. When used in combination, cisplatin and AZD6738 resolve ATM-deficient lung cancer xenografts.
[References]

[1]. choi my, fecteau jf, brown j, et al. induction of proliferation sensitizes chronic lymphocytic leukemia cells to apoptosis mediated by the atr inhibitor azd6738. cancer research, 2014, 74(19 supplement): 5485-5485.
[2]. checkley s, maccallum l, yates j, et al. bridging the gap between in vitro and in vivo: dose and schedule predictions for the atr inhibitor azd6738. scientific reports, 2015, 5.
[3]. guichard sm, brown e, odedra r, et al. the pre-clinical in vitro and in vivo activity of azd6738: a potent and selective inhibitor of atr kinase. cancer research, 2013, 73(8 supplement): 3343-3343.
Spectrum DetailBack Directory
[Spectrum Detail]

AZD6738(1352226-88-0)1HNMR
1352226-88-0 suppliers list
Company Name: Wuhan Jingkang en Biomedical Technology Co., Ltd
Tel: +8613720134139 , +8613720134139
Website: http://www.jknbiochem.com/
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Website: www.atkchemical.com
Company Name: career henan chemical co
Tel: +86-0371-86658258 +8613203830695 , +8613203830695
Website: www.coreychem.com/
Company Name: BOC Sciences
Tel: +1-631-485-4226
Website: www.bocsci.com/
Company Name: Chongqing Chemdad Co., Ltd
Tel: +86-023-6139-8061 +86-86-13650506873 , +86-86-13650506873
Website: http://www.chemdad.com/
Company Name: Guangzhou Yuheng Pharmaceutical Technology Co., Ltd
Tel: +8613580539051 , +8613580539051
Website: www.yuhengpharm.com
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000 , +1-00000000000
Website: https://www.targetmol.com/
Company Name: HANGZHOU CLAP TECHNOLOGY CO.,LTD
Tel: 86-571-88216897,88216896 13588875226 , 13588875226
Website: www.hzclap.com/en
Company Name: Wuhan Nutra Biotechnology Co.,Ltd
Tel: +8617786394783 , +8617786394783
Website: www.nutrabiotechchem.com/
Company Name: Zhejiang J&C Biological Technology Co.,Limited
Tel: +1-2135480471 +1-2135480471 , +1-2135480471
Website: https://www.sarms4muscle.com
Company Name: CR Corporation Limited
Tel: +8613062833949 , +8613062833949
Website: http://www.crcorporation.cn/
Company Name: Hangzhou Proserre Chemical Co.,Ltd.
Tel: +86-571-86088112
Website: https://www.proserre.com/
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105 , +1-13798911105
Website: https://www.invivochem.com/
Company Name: TargetMol Chemicals Inc.
Tel:
Website: www.targetmol.com/
Company Name: ShenZhen Trendseen Biological Technology Co.,Ltd.
Tel: 13417589054 , 13417589054
Website: www.approvedhomemanagement.com/ShowSupplierProductsList1962465/0.htm
Company Name: Wuhan Topule Biopharmaceutical Co., Ltd
Tel: +8618327326525 , +8618327326525
Website: topule.com/
Company Name: Shanghai Acmec Biochemical Technology Co., Ltd.
Tel: +undefined18621343501 , +undefined18621343501
Website: www.acmec.com.cn/
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Website: www.aladdinsci.com/
Tags:1352226-88-0 Related Product Information
1687736-54-4 1831110-54-3 199666-03-0 914471-09-3 1793053-37-8 312756-74-4 177355-84-9 1538604-68-0 1218942-37-0 1446502-11-9 1044870-39-4 1204669-58-8